STRATIFY JCV is a blood test that detects anti-JC virus (JCV) antibodies to help assess the risk of PML in patients with MS

March 21, 2012 /

MS Drug Therapies

If you are unable to read the HTML email below, please view it online.


Visit STRATIFYJCV.com/US to watch an educational presentation from a nationally recognized MS expert

	Robert J. Fox, MD, FAAN Staff Neurologist and Medical Director, Cleveland Clinic Mellen Center for MS, Cleveland, OH	Bhupendra O. Khatri, MD Medical Director, Regional MS Center at Aurora St. Luke’s Medical Center, Milwaukee, WI	Carlo S. Tornatore, MD Vice Chairman for Clinical Affairs, Department of Neurology, Georgetown University Medical School. Director and Vice President of the MS Center, Georgetown University Hospital, Washington, DC
	STRATIFY JCV is a blood test that detects anti-JC virus (JCV) antibodies to help assess the risk of PML in patients with MS.¹ STRATIFY JCV is designed to detect the presence of antibodies to JCV in serum or plasma. Antibody testing is a reliable indicator of exposure to JCV, even when the virus is latent.¹ Prior exposure to JCV is required for the development of progressive multifocal leukoencephalopathy (PML).²
	To order STRATIFY JCV call Quest Diagnostics^® at 1-866-MYQUESTTest Code: 90257(X)
	STRATIFY JCV Antibody ELISA is a laboratory developed test that has been analytically validated for multiple sclerosis patients by Quest Diagnostics (at its Focus Diagnostics laboratory) based on technology licensed from Biogen Idec. References 1. Gorelik L, Lerner M, Bixler S, et al. Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol. 2010;68(3):295-303. 2. Sunyaev SR, Lugovskoy A, Simon K, Gorelik L. Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML). PLoS Genet. 2009;5(2):e1000368. Epub 2009 Feb 6. If you would like to receive further communications from BIOGEN IDEC, click here. To forward a link to this e-mail to a colleague, click here. This e-mail is for healthcare professionals only.This e-mail is intended for residents of the United States, Puerto Rico, and US territories only. BIOGEN IDEC and the BIOGEN IDEC logo are registered trademarks of Biogen Idec. STRATIFY JCV and the STRATIFY JCV logo are trademarks of Biogen Idec. The ELAN logo is a registered trademark of the Elan Corporation, plc. If you prefer not to receive e-mails from BIOGEN IDEC in the future, click here.

..

Comments are appreciated. Note that All comments are moderated

If not yet receiving our weekly e-Newsletter – Click here to: REGISTER –

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

…………………………

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews

Stay informed with MS news and information - Sign-up here

For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT

Share: